Labcorp Holdings Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Labcorp Holdings wird ein jährliches Gewinn- und Umsatzwachstum von 19.1% bzw. 3.7% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 21.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 15.8% betragen.
Wichtige Informationen
19.1%
Wachstumsrate der Gewinne
21.1%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 17.1% |
| Wachstumsrate der Einnahmen | 3.7% |
| Zukünftige Eigenkapitalrendite | 15.8% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 13 Jun 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?
Jun 13
Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year
May 08Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72
Apr 30Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72
Apr 15Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark
Apr 06Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear
Apr 01Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72
Feb 25We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings
Feb 22An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued
Feb 21Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72
Jan 31Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 30Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72
Jan 15Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio
Jan 05Laboratory Corporation: Multiple Updates, Same Investment Conclusion
Dec 02Laboratory Corp.: Rate On Capital Deployed Contracting, Hold
Sep 14Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea
Jul 05Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts
Jul 04Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?
Jun 23Laboratory Corporation: Predictability Of Cash Flows Less Visible
Jun 21Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?
May 26Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher
Mar 16Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate
Mar 02Laboratory Corporation of America Non-GAAP EPS of $4.14 in-line, revenue of $3.7B misses by $40M, introduces FY23 outlook
Feb 16At US$254, Is It Time To Put Laboratory Corporation of America Holdings (NYSE:LH) On Your Watch List?
Jan 30Laboratory Corporation: Plenty Of Growth Runway
Jan 19Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 16Laboratory Corporation of America declares $0.72 dividend
Jan 12Returns At Laboratory Corporation of America Holdings (NYSE:LH) Are On The Way Up
Dec 07Is There An Opportunity With Laboratory Corporation of America Holdings' (NYSE:LH) 25% Undervaluation?
Nov 24Laboratory Corporation: Buy Rating Holds Following Solid Mid-Level Growth
Nov 08Laboratory Corporation of America Q3 2022 Earnings Preview
Oct 26Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 13,990 | 1,221 | 1,446 | 1,993 | 8 |
| 12/31/2025 | 13,410 | 1,092 | 1,238 | 1,708 | 13 |
| 12/31/2024 | 12,808 | 955 | 1,071 | 1,513 | 13 |
| 3/31/2024 | 12,300 | 399 | 767 | 1,276 | N/A |
| 12/31/2023 | 12,162 | 379 | 874 | 1,328 | N/A |
| 9/30/2023 | 12,058 | 583 | 913 | 1,298 | N/A |
| 6/30/2023 | 11,868 | 677 | 910 | 1,273 | N/A |
| 3/31/2023 | 11,757 | 789 | 1,122 | 1,513 | N/A |
| 12/31/2022 | 11,864 | 1,002 | 1,417 | 1,847 | N/A |
| 9/30/2022 | 12,990 | 1,518 | 1,415 | 1,895 | N/A |
| 6/30/2022 | 14,186 | 1,829 | 1,788 | 2,303 | N/A |
| 3/31/2022 | 15,104 | 2,028 | 1,826 | 2,308 | N/A |
| 12/31/2021 | 13,136 | 2,195 | 2,597 | 3,018 | N/A |
| 9/30/2021 | 16,555 | 2,763 | 2,777 | 3,187 | N/A |
| 6/30/2021 | 16,388 | 2,879 | 2,836 | 3,206 | N/A |
| 3/31/2021 | 15,316 | 2,643 | 2,719 | 3,089 | N/A |
| 12/31/2020 | 13,979 | 1,556 | 1,754 | 2,135 | N/A |
| 9/30/2020 | 12,442 | 845 | 1,520 | 1,931 | N/A |
| 6/30/2020 | 11,475 | 362 | 1,174 | 1,600 | N/A |
| 3/31/2020 | 11,587 | 321 | 1,070 | 1,483 | N/A |
| 12/31/2019 | 11,555 | 824 | 1,045 | 1,445 | N/A |
| 9/30/2019 | 11,389 | 755 | 967 | 1,361 | N/A |
| 6/30/2019 | 11,292 | 853 | 758 | 1,158 | N/A |
| 3/31/2019 | 11,276 | 896 | 890 | 1,292 | N/A |
| 12/31/2018 | 11,333 | 884 | 926 | 1,305 | N/A |
| 9/30/2018 | 11,291 | 1,414 | 1,030 | 1,384 | N/A |
| 6/30/2018 | 11,081 | 1,266 | 1,198 | 1,529 | N/A |
| 3/31/2018 | 10,743 | 1,217 | 1,137 | 1,452 | N/A |
| 12/31/2017 | 10,308 | 1,227 | N/A | 1,498 | N/A |
| 9/30/2017 | 9,951 | 724 | N/A | 1,382 | N/A |
| 6/30/2017 | 9,702 | 732 | N/A | 1,235 | N/A |
| 3/31/2017 | 9,556 | 751 | N/A | 1,274 | N/A |
| 12/31/2016 | 9,553 | 712 | N/A | 1,197 | N/A |
| 9/30/2016 | 9,295 | 658 | N/A | 1,112 | N/A |
| 6/30/2016 | 9,192 | 633 | N/A | 1,150 | N/A |
| 3/31/2016 | 9,029 | 599 | N/A | 1,197 | N/A |
| 12/31/2015 | 8,506 | 438 | N/A | 982 | N/A |
| 9/30/2015 | 7,774 | 447 | N/A | 812 | N/A |
| 6/30/2015 | 7,056 | 430 | N/A | 699 | N/A |
| 3/31/2015 | 6,353 | 401 | N/A | 510 | N/A |
| 12/31/2014 | 6,012 | 511 | N/A | 739 | N/A |
| 9/30/2014 | 5,936 | 518 | N/A | 774 | N/A |
| 6/30/2014 | 5,846 | 529 | N/A | 833 | N/A |
| 3/31/2014 | 5,798 | 540 | N/A | 763 | N/A |
| 12/31/2013 | 5,808 | 574 | N/A | 819 | N/A |
| 9/30/2013 | 5,777 | 568 | N/A | 824 | N/A |
| 6/30/2013 | 5,734 | 567 | N/A | 794 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: LHDas prognostizierte Gewinnwachstum (19.1% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: LHDie Erträge des Unternehmens (19.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.8% pro Jahr).
Hohe Wachstumserträge: LHDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: LHDie Einnahmen des Unternehmens (3.7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).
Hohe Wachstumseinnahmen: LHDie Einnahmen des Unternehmens (3.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: LHDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (15.8%).